“…In contrast, GML, regardless of pretreatment or cotreatment, reversed the DSS-induced dysbiosis in microbial diversity. Accordingly, butyric acid and propionic acid, which were marginally restored in the pre-GML+DSS group relative to the DSS group, could contribute to ameliorating experimental colitis ( 28 ). The aforementioned results were consistent with the previous reports that Bifidobacterium has been regarded as an acetate-to-butyrate converting organism, and the synthetic butyrate, in turn, promoted the growth of Bifidobacterium and Lactobacillus in the gut ( 34 , 35 ).…”